Soya, maize and sorghum ready-to-use therapeutic foods are more effective in correcting anaemia and iron deficiency than the standard ready-to-use therapeutic food: Randomized controlled trial
Autor: | Paluku Bahwere, Kate Sadler, Hitoshi Murakami, Sylvester Kathumba, Chrissy Banda, Steve Collins, Elizabeth Maganga, Peter Akomo |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
Malawi Arachis Logistic regression Gastroenterology Santé publique law.invention 0302 clinical medicine Randomized controlled trial law Epidemiology Prevalence 030212 general & internal medicine biology Anemia Iron-Deficiency lcsh:Public aspects of medicine Iron deficiency Treatment Outcome Milk Severe acute malnutrition Child Preschool Female Analysis of variance Research Article medicine.medical_specialty Iron Severe Acute Malnutrition 030209 endocrinology & metabolism Anaemia Zea mays 03 medical and health sciences Ready-to-use therapeutic food Internal medicine medicine Animals Humans Sorghum Soluble transferrin receptor Food Formulated business.industry Public Health Environmental and Occupational Health Infant lcsh:RA1-1270 medicine.disease Therapeutic food biology.protein Soybeans business Edible Grain |
Zdroj: | BMC public health, 19 (1 BMC Public Health BMC Public Health, Vol 19, Iss 1, Pp 1-15 (2019) |
Popis: | Background: The prevalence of anaemia and iron deficiency (ID) among children with severe acute malnutrition (SAM) and their correction during nutritional rehabilitation are not well documented. This study assessed anaemia and ID prevalence and their predictors at start of SAM treatment, and the efficacy of their treatment and effect on gut health of two novel Ready-To-Use Therapeutic foods (RUTF) prepared from soybean, maize and sorghum (SMS) with (MSMS-RUTF) or without added milk (FSMS-RUTF) compared to those of the standard formulation prepared from peanut and milk (PM-RUTF). Methods: This was a 3-arms parallel groups, simple randomised, controlled non-inferiority trial in 6-59 months old Central Malawian children with SAM. Anaemia was defined using altitude- and ethnicity-adjusted haemoglobin. Iron status was defined using soluble transferrin receptor (sTfR) and body iron stores (BIS). We used Pearson's chi-square test, t-test for paired or unpaired data, Kruskal-Wallis test for between-arm differences as appropriate and logistic regression to identify independent predictors of anaemia or iron deficiency anaemia (IDA). Results: The sample size was 389. At admission, the prevalence [%(95%CI)] of anaemia was 48.9(41.4-56.5)% while that of ID and IDA were 55.7(48.6-62.5)% and 34.3(28.2-41.0)% when using sTfR criterion and 29.1(24.4-34.4)% and 28.9(23.7-34.9)% when using BIS criterion, respectively. At discharge, nutrition rehabilitation with SMS-RUTF was associated with the lowest prevalence of anaemia [12.0(6.9-20.3)% for FSMS-RUTF, 18.2(11.9-26.8)% for MSMS-RUTF and 24.5(15.8-35.9)% for PM-RUTF; p = 0.023] and IDA [7.9(3.4-17.3)% for FSMS-RUTF, 10.9(4.8-22.6)% for MSMS-RUTF and 20.5(10.7-35.5)% for PM-RUTF; p = 0.028]. SMS-RUTF was also associated with the highest increase in BIS [Change in BIS (95%CI)] among the iron deplete at admission [6.2 (3.7; 8.6), 3.2 (0.8; 5.6), 2.2 (0.2; 4.3) for the same study arms; Anova p = 0.045]. Compared to P-RUTF, FSMS-RUTF had the highest adjusted recovery rate [OR (95%CI = 0.3 (0.2-0.5) with p < 0.001 for FSMS-RUTF and 0.6 (0.3-1.0) with p = 0.068 for MSMS-RUTF]. No effect of iron content on risk of iron overload or gut inflammation was observed. Conclusions: Anaemia and ID are common among children with SAM. FSMS-RUTF is more efficacious in treating anaemia and correcting BIS among this group than PM-RUTF. Trial registration: This study was registered on 15 April 2015 (PACTR201505001101224). SCOPUS: ar.j info:eu-repo/semantics/published |
Databáze: | OpenAIRE |
Externí odkaz: |